Redox Sensitive Cysteine Residues as Crucial Regulators of Wild-Type and Mutant p53 Isoforms

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• The tumor suppressor protein p53 is crucial for preventing neoplasms by regulating cell growth.
• Missense mutations in the TP53 gene occur in over half of all cancers, leading to oncogenic p53 isoforms.
• Both wild-type and mutant p53 proteins influence cellular redox state, exhibiting antioxidant and prooxidant functions, respectively.

Purpose of the Study:

• To explore the novel concept of p53 protein's sensitivity to cellular redox state.
• To discuss structural and functional alterations in p53 due to post-translational modifications of redox-sensitive cysteine residues.
• To review therapeutic strategies targeting cysteine residues in mutant p53 isoforms for anticancer therapies.

Main Methods:

• Literature review focusing on p53 protein structure, function, and redox regulation.
• Analysis of post-translational modifications of cysteine residues in p53.
• Discussion of small molecule-based therapeutic approaches targeting mutant p53.

Main Results:

• Wild-type p53 acts as a tumor suppressor, while mutant p53 can promote oncogenesis.
• Redox-sensitive cysteine residues in p53 are critical for structural integrity and zinc binding.
• Post-translational modifications of these cysteines significantly alter p53 structure and function.
• Mutant p53 isoforms display altered redox regulation, contributing to cancer progression.

Conclusions:

• The cellular redox state profoundly impacts p53 protein structure and function.
• Targeting redox-sensitive cysteines in mutant p53 offers a promising avenue for anticancer drug development.
• Understanding p53's redox sensitivity is key to developing novel therapies for TP53-mutated cancers.